Evidence map›Paper›PMID 33148888›Full record

ArticleJCI insight2020

Elevated CCL2 causes Leydig cell malfunction in metabolic syndrome.

Qingkui Jiang, Constanze C Maresch, Sebastian Friedrich Petry, Agnieszka Paradowska-Dogan, Sudhanshu Bhushan, Yongsheng Chang, Christine Wrenzycki, Hans-Christian Schuppe, Petr Houska, Michaela F Hartmann and 3 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Keratinocytes: pleiotropic orchestrators of cutaneous immunity and Inflammation - Emerging therapeutic paradigms in dermatological pathologies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Role of Testosterone in the Elderly: What Do We Know?International journal of molecular sciences · 2022
    Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 6 countries.

Qingkui JiangClinical Research Unit, Centre of Internal Medicine, Justus-Liebig-University (JLU), Giessen, Germany.
Constanze C MareschClinical Research Unit, Centre of Internal Medicine, Justus-Liebig-University (JLU), Giessen, Germany.
Sebastian Friedrich PetryClinical Research Unit, Centre of Internal Medicine, Justus-Liebig-University (JLU), Giessen, Germany.
Agnieszka Paradowska-DoganDepartment of Gynecological Endocrinology and Reproductive Medicine, University Clinic Bonn, Bonn, Germany.
Sudhanshu BhushanInstitute of Anatomy and Cell Biology, Department of Reproductive Biology, JLU, Giessen, Germany.
Yongsheng ChangTianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.
Christine WrenzyckiDepartment of Molecular Reproductive Medicine, Clinic for Veterinary Obstetrics, Gynecology and Andrology, and.
Hans-Christian SchuppeDepartment of Urology, Pediatric Urology and Andrology, JLU, Giessen, Germany.
Petr HouskaClinical Research Unit, Centre of Internal Medicine, Justus-Liebig-University (JLU), Giessen, Germany.
Michaela F HartmannSteroid Research and Mass Spectrometry Unit, Division of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, JLU, Giessen, Germany.
Stefan A WudySteroid Research and Mass Spectrometry Unit, Division of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, JLU, Giessen, Germany.
Lanbo ShiPublic Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
Thomas LinnClinical Research Unit, Centre of Internal Medicine, Justus-Liebig-University (JLU), Giessen, Germany.
Justus-Liebig-Universität Gießen · DEGerman Center for Pediatric and Adolescent Rheumatology · DEInstitut de Médecine de la Reproduction · FRKarolinska University Hospital · SERutgers, The State University of New Jersey · USTianjin Medical University · CNUniversitätsklinikum Gießen und Marburg · DEUniversity of Bonn · DEUniversity of Veterinary Medicine · HU

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
NIDDK NIH HHS P30 DK020541
6 · The paper itself

Abstract

Metabolic syndrome (MetS), which is associated with chronic inflammation, predisposes males to hypogonadism and subfertility. The underlying mechanism of these pathologies remains poorly understood. Homozygous leptin-resistant obese db/db mice are characterized by small testes, low testicular testosterone, and a reduced number of Leydig cells. Here we report that IL-1β, CCL2 (also known as MCP-1), and corticosterone concentrations were increased in the testes of db/db mice relative to those in WT controls. Cultured murine and human Leydig cells responded to cytokine stress with increased CCL2 release and apoptotic signals. Chemical inhibition of CCL2 rescued Leydig cell function in vitro and in db/db mice. Consistently, we found that Ccl2-deficient mice fed with a high-energy diet were protected from testicular dysfunction compared with similarly fed WT mice. Finally, a cohort of infertile men with a history of MetS showed that reduction of CCL2 plasma levels could be achieved by weight loss and was clearly associated with recovery from hypogonadism. Taken together, we conclude that CCL2-mediated chronic inflammation is, to a large extent, responsible for the subfertility in MetS by causing damage to Leydig cells.

Indexed as

AnimalsChemokine CCL2Diabetes Mellitus, ExperimentalHumansHypogonadismInfertility, MaleLeydig CellsMaleMetabolic SyndromeMiceMice, Inbred C57BLObesityCCL2 protein, humanCcl2 protein, mouseChemokine CCL2ChemokinesEndocrinologyFertilityReproductive BiologyUrology

Identifiers

PMID33148888
PMCPMC7710294
OpenAlexW3096000161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.